BamSEC and AlphaSense Join Forces
Learn More

Ocugen, Inc.

NASDAQ: OCGN    
Share price (8/22/25): $1.01    
Market cap (8/22/25): $295 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 14 pages Placement Agency Agreement August 8, 2025
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Third Amendment to the Exclusive License Agreement
12/34/56
EX-10.4
from 8-K 5 pages Lock-Up Agreement [●], 2025
12/34/56
EX-10.3
from 8-K 19 pages Support Agreement
12/34/56
EX-10.2
from 8-K 19 pages Support Agreement
12/34/56
EX-10.1
from 8-K 177 pages Agreement and Plan of Merger by and Among Carisma Therapeutics Inc., Azalea Merger Sub, Inc., Orthocellix, Inc. and Ocugen, Inc. Dated as of June 22, 2025
12/34/56
EX-10.38
from 10-K 12 pages Material contract
12/34/56
EX-10.1
from 8-K/A 15 pages Subscription Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Executive Employment Agreement
12/34/56
EX-10.25
from 10-K 2 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Second Amendment to the Exclusive License Agreement Between the Washington University| and Ocugen, Inc
12/34/56
EX-10.22
from 10-K 2 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. 3rd Amendment to Co-Development and Commercialization Agreement
12/34/56
EX-10.1
from 8-K 8 pages Ocugen, Inc. 2019 Equity Incentive Plan Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Executive Employment Agreement
12/34/56
EX-10.31
from 10-K 2 pages Amendment #1 to Amended & Restated Executive Employment Agreement
12/34/56
EX-10.30
from 10-K 8 pages Amended & Restated Executive Employment Agreement
12/34/56
EX-10.23
from 10-K 2 pages First Amendment to the Exclusive License Agreement Between the Washington University and Ocugen, Inc
12/34/56
EX-10.21
from 10-K 2 pages 2nd Amendment to the Co-Development and Commercialization Agreement
12/34/56
EX-10.10
from 10-K 3 pages Ocugen, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.9
from 10-K 4 pages Ocugen, Inc. Non-Qualified Stock Option Inducement Award Agreement
12/34/56